HIV-related opportunistic infections are still relevant in 2015

Topics in Antiviral Medicine

Volumn 23, Issue 3, 2015, Pages 116-119

  Masur, Henry ^a  

^a GEORGE WASHINGTON UNIVERSITY SCHOOL OF MEDICINE AND HEALTH SCIENCES   (United States)

Author keywords

Clostridium difficile; Cryptococcal meningitis; HIV; Opportunistic infections; Pneumocystis jiroveci pneumonia; Shigellosis

Indexed keywords

AMPHOTERICIN B; ANTIRETROVIRUS AGENT; FLUCONAZOLE; LACTATE DEHYDROGENASE;

AIDS RELATED COMPLEX; ARTICLE; ASYMPTOMATIC CRYPTOCOCCAL ANTIGENEMIA; CD4+ T LYMPHOCYTE; CLOSTRIDIUM DIFFICILE INFECTION; CRYPTOCOCCAL MENINGITIS; CRYPTOCOCCOSIS; DIARRHEA; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOFLUORESCENCE; INCIDENCE; MORTALITY; PNEUMOCYSTIS PNEUMONIA; POLYMERASE CHAIN REACTION; PREVENTION AND CONTROL; SHIGELLOSIS; AIDS-RELATED OPPORTUNISTIC INFECTIONS; CLOSTRIDIUM INFECTIONS; DYSENTERY, BACILLARY; HIV INFECTIONS; MENINGITIS, CRYPTOCOCCAL; PEPTOCLOSTRIDIUM DIFFICILE; PNEUMONIA, PNEUMOCYSTIS; PRACTICE GUIDELINE;

AIDS-RELATED OPPORTUNISTIC INFECTIONS; ANTI-RETROVIRAL AGENTS; CLOSTRIDIUM DIFFICILE; CLOSTRIDIUM INFECTIONS; DYSENTERY, BACILLARY; HIV INFECTIONS; HUMANS; INCIDENCE; MENINGITIS, CRYPTOCOCCAL; PNEUMONIA, PNEUMOCYSTIS; PRACTICE GUIDELINES AS TOPIC;

EID: 84943164088     PISSN: 21615861     EISSN: 21615853     Source Type: Journal    
DOI: None     Document Type: Article

References (11)

1. National Institutes of Health, Centers for Disease Control and Prevention, and Infectious Diseases Society of America. Guidelines for prevention and treatment of opportunistic infections in HIV-infected adults and adolescents. https://aidsinfo.nih.gov/contentfiles/ lvguidelines/adult_oi.pdf. Accessed on September 14, 2015.
2. Park BJ, Wannemuehler KA, Marston BJ, Govender N, Pappas PG, Chiller TM. Estimation of the current global burden of cryptococcal meningitis among persons living with HIV/AIDS. AIDS. 2009; 23(4):525-530.
3. Mfinanga S, Chanda D, Kivuyo SL, et al. Cryptococcal meningitis screening and community-based early adherence support in people with advanced HIV infection starting antiretroviral therapy in Tanzania and Zambia: an open-label, randomised controlled trial. Lancet. 2015;385(9983):2173-2182.
4. Jarvis JN, Lawn SD, Wood R, Harrison TS. Cryptococcal antigen screening for patients initiating antiretroviral therapy: time for action. Clin Infect Dis. 2010;51(12):1463-1465.
5. World Health Organization. Rapid advice: diagnosis, prevention and management of cryptococcal disease in HIV-infected adults, adolescents and children. http://whqlibdoc.who.int/publications/2011/ 9789241502979_eng.pdf. Accessed on August 20, 2015.
6. McKenney J, Smith RM, Chiller TM, et al. Prevalence and correlates of cryptococcal antigen positivity among AIDS patients-United States, 1986-2012. MMWR Morb Mortal Wkly Rep. 2014;63(27):585-587.
7. McKenney J, Bauman S, Neary B, et al. Prevalence, correlates, and outcomes of cryptococcal antigen positivity among patients with AIDS, United States, 1986-2012. Clin Infect Dis. 2015;60(6):959-965.
8. Bowen A, Hurd J, Hoover C, et al. Importation and domestic transmission of Shigella sonnei resistant to ciprofloxacin-United States, May 2014-February 2015. MMWR Morb Mortal Wkly Rep. 2015; 64(12):318-320.
9. Sanchez TH, Brooks JT, Sullivan PS, et al. Bacterial diarrhea in persons with HIV infection, United States, 1992-2002. Clin Infect Dis. 2005;41:1621-1627.
10. Johnson S, Louie TJ, Gerding DN, et al. Vancomycin, metronidazole, or tolevamer for Clostridium difficile infection: results from two multinational, randomized, controlled trials. Clin Infect Dis. 2014;59(3):345-354.
11. Cohen SH, Gerding DN, Johnson S, et al. Clinical practice guidelines for Clostridium difficile infection in adults: 2010 update by the Society for Healthcare Epidemiology of America (SHEA) and the Infectious Diseases Society of America (IDSA). Infect Control Hosp Epidemiol. 2010;31(5):431-455.